Tomas Becerril-Almeida
Seguro Social, MEX, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Advances in MicroRNAs in Pathophysiology of Duchenne Muscular Dystrophy.
Journal: Muscle & nerve
Published: May 23, 2024
The muscle regeneration marker FOXP3 is associated with muscle injury in Duchenne muscular dystrophy.
Journal: Brain & development
Published: December 13, 2023
Circulating Nrf2, Glutathione, and Malondialdehyde Correlate with Disease Severity in Duchenne Muscular Dystrophy.
Journal: Antioxidants (Basel, Switzerland)
Published: February 07, 2023
Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters.
Journal: Acta neurologica Scandinavica
Published: May 12, 2022
Pro-inflammatory monocytes are increased in Duchenne muscular dystrophy and suppressed with omega-3 fatty acids: A double-blind, randomized, placebo-controlled pilot study.
Journal: European journal of neurology
Published: August 18, 2021
Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice.
Journal: American journal of physical medicine & rehabilitation
Published: June 11, 2020
Body composition and body mass index in Duchenne muscular dystrophy: Role of dietary intake.
Journal: Muscle & nerve
Published: September 04, 2018
Evidence of muscle loss delay and improvement of hyperinsulinemia and insulin resistance in Duchenne muscular dystrophy supplemented with omega-3 fatty acids: A randomized study.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: April 24, 2018
Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: July 14, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026